visa-g-normalised

VISA-G (normalised)

An improved, patient-friendly version of VISA-G for greater trochanteric pain syndrome. The usual hip pain question uses a conventional scale (0 best, 10 worst) that matches how patients usually rate pain, while the calculated score remains equivalent to the original VISA-G.

Specialties: physiotherapy, orthopaedics, sports_medicine|Areas: hip

Time:5 min
Pages:2
Questions:8
Free

One Time Calculator

Get instant validated scores or print a PDF version

Example Assessment Result

Patient-Reported Outcome Measure

Total Score
72/100
Clinical InterpretationModerate Function
Section 1
Completed (8/10)
Section 2
Completed (7/10)
Remaining sections
All responses submitted
Premium

Track Over Time

Prove your procedures help patients with outcome data

TimingBaseline
Date15 Jan 2024

Score65
30-Day Money-Back Guarantee

Free setup for clinics and clinicians

Key facts

Score direction
Higher is better
Meaningful change
A change of approximately 6.9 to 18.4 points is considered the smallest detectable change (SDC) for VISA-G, and changes of 10 points or more are generally considered clinically significant. Because VISA-G (normalised) calculates the total score in the same direction as VISA-G, the same thresholds can be used for interpreting meaningful change.
Scoring
The form comprises eight questions with a maximum total score of 100 points. Question 1 is presented in a patient-friendly normalised direction, where 0 represents no pain and 10 represents worst pain, then reverse-trans…
Time to complete
5 min
Questions
8
Licensing
Available free of charge; Patient Watch charges only for platform services

About the VISA-G (normalised)

VISA-G (normalised) is an improved presentation of the Victorian Institute of Sport Assessment for Gluteal Tendinopathy questionnaire, designed for patient ease of use. It keeps the same clinical content and score interpretation as VISA-G, but presents the usual hip pain question with conventional pain-scale direction where 0/10 is best and 10/10 is worst. This matches typical VAS and NRS pain scoring that patients already understand, reducing confusion from the original scale where higher numbers meant less pain. Functional and activity questions retain their original wording. The calculated total remains equivalent to the original VISA-G, so clinicians can compare results and apply the same thresholds.

Prevalence:
common

Medical Specialties

Physiotherapy
Orthopaedics
Sports Medicine

Anatomic Areas

Hip

Clinical Indications

Greater Trochanteric Pain Syndrome
Gtps
Hip Bursitis
Gluteal Tendinopathy

Developer Information

Based on the VISA-G developed by Fearon AM and colleagues (2015). Normalised presentation adapted for patient ease of use while preserving score equivalence.

Copyright & Licensing

The VISA-G is freely available for clinical and research use without licensing fees. Users should cite the original development and validation study when using the questionnaire.

Administration Instructions

In this questionnaire, the term "pain" refers specifically to your hip pain. For question 1, 0/10 is best and 10/10 is worst - the same direction most people use when rating pain. The final score is calculated in the same direction as the original VISA-G.

Scoring Methodology

The form comprises eight questions with a maximum total score of 100 points. Question 1 is presented in a patient-friendly normalised direction, where 0 represents no pain and 10 represents worst pain, then reverse-transformed using 10 minus the selected response. Questions 2-7 retain the original VISA-G categorical options and scores. Question 8 is completed as either A, B or C only with the original duration bands and scores. Item scores are summed to produce a total score ranging from 0 (worst symptoms) to 100 (asymptomatic). Higher scores indicate better function and fewer symptoms.

Scoring:
Higher is better

Meaningful Change Threshold

A change of approximately 6.9 to 18.4 points is considered the smallest detectable change (SDC) for VISA-G, and changes of 10 points or more are generally considered clinically significant. Because VISA-G (normalised) calculates the total score in the same direction as VISA-G, the same thresholds can be used for interpreting meaningful change.

Score Interpretation

Understanding what your score means

severe

0 - 25

Severe disability - significant impact on daily activities and quality of life

moderate

26 - 50

Moderate disability - noticeable limitations in function and activities

mild

51 - 75

Mild disability - some functional limitations but able to perform most activities

minimal

76 - 100

Minimal to no disability - excellent function with little to no impact from symptoms

Clinical Limitations & Considerations

VISA-G (normalised) improves patient ease of use by changing the response direction for the usual hip pain question, but keeps the calculated score equivalent to VISA-G. Clinicians should avoid mixing raw item responses from the original and normalised forms without accounting for this display-direction change.

Frequently asked questions

What does a mild VISA-G (normalised) score mean?

A VISA-G (normalised) score of 51 to 75 is classified as mild. Mild disability - some functional limitations but able to perform most activities

What does a severe VISA-G (normalised) score mean?

A VISA-G (normalised) score of 0 to 25 is classified as severe. Severe disability - significant impact on daily activities and quality of life

What does a minimal VISA-G (normalised) score mean?

A VISA-G (normalised) score of 76 to 100 is classified as minimal. Minimal to no disability - excellent function with little to no impact from symptoms

What does a moderate VISA-G (normalised) score mean?

A VISA-G (normalised) score of 26 to 50 is classified as moderate. Moderate disability - noticeable limitations in function and activities

Related Outcome Measures

Other clinical questionnaires for similar specialties and conditions

This questionnaire is provided free of charge. Patient Watch charges only for platform services (data storage, automated reminders, analytics) - not for use of clinical instruments. This non-commercial model supports academic and clinical use.View full licensing disclosure